SCI Pharmtech Statistics
Total Valuation
SCI Pharmtech has a market cap or net worth of TWD 10.13 billion. The enterprise value is 10.69 billion.
Market Cap | 10.13B |
Enterprise Value | 10.69B |
Important Dates
The next estimated earnings date is Tuesday, March 18, 2025.
Earnings Date | Mar 18, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
SCI Pharmtech has 119.51 million shares outstanding. The number of shares has increased by 10.21% in one year.
Current Share Class | n/a |
Shares Outstanding | 119.51M |
Shares Change (YoY) | +10.21% |
Shares Change (QoQ) | +0.17% |
Owned by Insiders (%) | 6.57% |
Owned by Institutions (%) | 3.86% |
Float | 68.68M |
Valuation Ratios
The trailing PE ratio is 20.78.
PE Ratio | 20.78 |
Forward PE | n/a |
PS Ratio | 7.10 |
PB Ratio | 1.87 |
P/TBV Ratio | 1.88 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 29.90, with an EV/FCF ratio of -15.35.
EV / Earnings | 22.09 |
EV / Sales | 7.57 |
EV / EBITDA | 29.90 |
EV / EBIT | 75.99 |
EV / FCF | -15.35 |
Financial Position
The company has a current ratio of 2.35, with a Debt / Equity ratio of 0.20.
Current Ratio | 2.35 |
Quick Ratio | 1.56 |
Debt / Equity | 0.20 |
Debt / EBITDA | 2.93 |
Debt / FCF | -1.58 |
Interest Coverage | 26.66 |
Financial Efficiency
Return on equity (ROE) is 10.14% and return on invested capital (ROIC) is 1.73%.
Return on Equity (ROE) | 10.14% |
Return on Assets (ROA) | 1.56% |
Return on Capital (ROIC) | 1.73% |
Revenue Per Employee | 5.91M |
Profits Per Employee | 2.03M |
Employee Count | 239 |
Asset Turnover | 0.22 |
Inventory Turnover | 1.82 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -10.74% in the last 52 weeks. The beta is -0.24, so SCI Pharmtech's price volatility has been lower than the market average.
Beta (5Y) | -0.24 |
52-Week Price Change | -10.74% |
50-Day Moving Average | 92.08 |
200-Day Moving Average | 90.51 |
Relative Strength Index (RSI) | 27.86 |
Average Volume (20 Days) | 186,003 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SCI Pharmtech had revenue of TWD 1.41 billion and earned 484.24 million in profits. Earnings per share was 4.08.
Revenue | 1.41B |
Gross Profit | 383.22M |
Operating Income | 159.94M |
Pretax Income | 584.24M |
Net Income | 484.24M |
EBITDA | 374.69M |
EBIT | 159.94M |
Earnings Per Share (EPS) | 4.08 |
Balance Sheet
The company has 543.51 million in cash and 1.10 billion in debt, giving a net cash position of -560.12 million or -4.69 per share.
Cash & Cash Equivalents | 543.51M |
Total Debt | 1.10B |
Net Cash | -560.12M |
Net Cash Per Share | -4.69 |
Equity (Book Value) | 5.42B |
Book Value Per Share | 45.36 |
Working Capital | 1.23B |
Cash Flow
In the last 12 months, operating cash flow was 96.11 million and capital expenditures -793.00 million, giving a free cash flow of -696.89 million.
Operating Cash Flow | 96.11M |
Capital Expenditures | -793.00M |
Free Cash Flow | -696.89M |
FCF Per Share | -5.83 |
Margins
Gross margin is 27.11%, with operating and profit margins of 11.32% and 34.26%.
Gross Margin | 27.11% |
Operating Margin | 11.32% |
Pretax Margin | 41.34% |
Profit Margin | 34.26% |
EBITDA Margin | 26.51% |
EBIT Margin | 11.32% |
FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 1.25, which amounts to a dividend yield of 1.48%.
Dividend Per Share | 1.25 |
Dividend Yield | 1.48% |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | 1 |
Payout Ratio | 30.85% |
Buyback Yield | -10.21% |
Shareholder Yield | -8.72% |
Earnings Yield | 4.81% |
FCF Yield | -6.88% |
Stock Splits
The last stock split was on July 27, 2023. It was a forward split with a ratio of 1.125.
Last Split Date | Jul 27, 2023 |
Split Type | Forward |
Split Ratio | 1.125 |
Scores
SCI Pharmtech has an Altman Z-Score of 4.43.
Altman Z-Score | 4.43 |
Piotroski F-Score | n/a |